主要文件

查看所有文档

308153

N-丙基-1,3-丙二胺

Name: <I>N</I>-丙基-1,3-丙二胺
Brand: ALDRICH

99%

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

CH₃CH₂CH₂NH(CH₂)₃NH₂

化学文摘社编号:

23764-31-0

分子量:

116.20

NACRES:

NA.22

PubChem Substance ID:

24858653

UNSPSC Code:

12352100

EC Number:

245-869-9

MDL number:

MFCD00008212

Assay:

99%

Form:

liquid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

99%

form

liquid

refractive index

n20/D 1.4451 (lit.)

bp

169 °C (lit.)

density

0.841 g/mL at 25 °C (lit.)

functional group

amine

SMILES string

CCCNCCCN

InChI

1S/C6H16N2/c1-2-5-8-6-3-4-7/h8H,2-7H2,1H3

InChI key

OWKYZAGJTTTXOK-UHFFFAOYSA-N

说明

Application

N-Propyl-1,3-propanediamine was used in the synthesis of 1-benzotriazolylmethyl-3-propylhexahydropyrimidine.

pictograms

GHS02,GHS05

signalword

Danger

hcodes

H226,H314

pcodes

P210 - P233 - P240 - P280 - P303 + P361 + P353 - P305 + P351 + P338

Hazard Classifications

Flam. Liq. 3 - Skin Corr. 1B

存储类别

3 - Flammable liquids

wgk

WGK 3

flash_point_f

129.2 °F - closed cup

flash_point_c

54 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

法规信息

危险化学品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Characterization of the Frmd7 Knock-Out Mice Generated by the EUCOMM/COMP Repository as a Model for Idiopathic Infantile Nystagmus (IIN).

Ahmed Salman et al.

Genes, 11(10) (2020-10-04)

In this study, we seek to exclude other pathophysiological mechanisms by which Frmd7 knock-down may cause Idiopathic Infantile Nystagmus (IIN) using the Frmd7.tm1a and Frmd7.tm1b murine models. We used a combination of genetic, histological and visual function techniques to characterize

Novel syntheses of hexahydropyrimidines and tetrahydroquinazolines.

Alan R Katritzky et al.

The Journal of organic chemistry, 67(9), 3115-3117 (2002-04-27)

1-Benzotriazolylmethyl-3-propylhexahydropyrimidine (1) and 1,3-bis(1H-1,2,3-benzotriazol-1-ylmethyl)-1,2,3,4-tetrahydroquinazoline (3) were readily prepared by reactions of N-propyl-1,3-propanediamine or 2-aminobenzylamine with benzotriazole and formaldehyde, respectively. Intermediate 1 reacted with alkyl and aryl Grignard reagents to produce N,N'-unsymmetrically substituted hexahydropyrimidines 2a,b in 90 and 92% yields, respectively.

Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.

C M Maragos et al.

Cancer research, 53(3), 564-568 (1993-02-01)

Cell-mediated antitumor effects have, in part, been attributed to the production of NO. Compounds which generate NO might, therefore, be useful in attenuating the growth of tumor cells. Six nitric oxide/nucleophile adducts that release NO spontaneously in solution were tested

全球贸易项目编号

货号	GTIN
308153-5G	04061826674468